The new test results show a significant increase in the use of slimming drugs among patients undergoing metabolic and bariatric surgery, signaling evolution in the treatment of obesity and type 2 diabetes. The research will be presented at the American College of Surgeons (ACS) clinical congress in Chicago, October 4-7. There is no universal approach […]